On 2025-05-12, Cue Biopharma, Inc. (CUE) announced earnings per share of $-0.17 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.14.
The next expected annoucement date for quarterly earnings is 2025-08-13, with an average estimated earnings per share of $-0.13 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-12 | 2025-03-31 | $-0.14 | $-0.17 |
| 2025-03-31 | 2024-12-31 | $-0.16 | $-0.13 |
| 2024-11-14 | 2024-09-30 | $-0.20 | $-0.17 |
| 2024-08-14 | 2024-06-30 | $-0.29 | $-0.20 |
| 2024-05-09 | 2024-03-31 | $-0.30 | $-0.25 |
| 2024-04-08 | 2023-12-31 | -- | $-0.28 |
| 2023-11-09 | 2023-09-30 | $-0.30 | $-0.24 |
| 2023-08-08 | 2023-06-30 | $-0.30 | $-0.29 |
| 2023-05-09 | 2023-03-31 | $-0.33 | $-0.29 |
| 2023-03-21 | 2022-12-31 | $-0.32 | $-0.37 |
| 2022-11-14 | 2022-09-30 | $-0.38 | $-0.31 |
| 2022-08-04 | 2022-06-30 | $-0.42 | $-0.37 |
| 2022-05-10 | 2022-03-31 | $-0.43 | $-0.44 |
| 2022-03-16 | 2021-12-31 | -- | $-0.26 |
| 2021-11-09 | 2021-09-30 | $-0.39 | $-0.41 |
| 2021-08-09 | 2021-06-30 | $-0.42 | $-0.33 |
| 2021-05-17 | 2021-03-31 | $-0.37 | $-0.41 |
| 2021-03-16 | 2020-12-31 | $-0.33 | $-0.37 |
| 2020-11-17 | 2020-09-30 | $-0.37 | $-0.34 |
| 2020-08-07 | 2020-06-30 | $-0.41 | $-0.38 |
| 2020-05-07 | 2020-03-31 | $-0.32 | $-0.48 |
| 2020-03-17 | 2019-12-31 | $-0.42 | $-0.37 |
| 2019-11-07 | 2019-09-30 | $-0.44 | $-0.31 |
| 2019-08-08 | 2019-06-30 | $-0.56 | $-0.46 |
| 2019-05-08 | 2019-03-31 | -- | $-0.54 |
| 2019-03-14 | 2018-12-31 | -- | $-0.58 |
| 2018-11-13 | 2018-09-30 | $-0.38 | $-0.62 |
| 2018-08-13 | 2018-06-30 | -- | $-0.36 |
| 2018-05-14 | 2018-03-31 | -- | $-0.37 |